The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years
- PMID: 12825872
- DOI: 10.1080/00365520310003002
The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years
Abstract
Background: Randomized controlled trials of sufficient power testing the long-term effect of screening for colorectal neoplasia only exist for faecal occult blood testing (FOBT). There is indirect evidence that flexible sigmoidoscopy (FS) may have a greater yield. The aim of this study was to determine the diagnostic yield of screening with FS or a combination of FS and FOBT in an average-risk population in an urban and combined urban and rural population in Norway.
Methods: 20,780 men and women (1:1), aged 50-64 years, were invited for once-only screening (FS only or a combination of FS and FOBT (1:1)) by randomization from the population registry. A positive FS was defined as a finding of any neoplasia or any polyp > or = 10 mm. A positive FS or FOBT qualified for colonoscopy.
Results: Overall attendance was 65%. Forty-one (0.3%) cases of CRC were detected. Any adenoma was found in 2208 (17%) participants and 545 (4.2%) had high-risk adenomas. There was no difference in diagnostic yield between the FS and the FS and FOBT group regarding CRC or high-risk adenoma. Work-up load comprised 2821 colonoscopies in 2524 (20%) screenees and 10% of screenees were recommended later colonoscopy surveillance. There were no severe complications at FS, but six perforations after therapeutic colonoscopy (1:336).
Conclusions: The present study bodes well for future management of a national screening programme, provided that follow-up results reflect adequate proof of a net benefit. It is highly questionable whether the addition of once-only FOBT to FS will contribute to this effect.
Similar articles
-
Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention).Scand J Gastroenterol. 2002 May;37(5):568-73. doi: 10.1080/00365520252903125. Scand J Gastroenterol. 2002. PMID: 12059059 Clinical Trial.
-
Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.Gut. 2010 Jan;59(1):62-8. doi: 10.1136/gut.2009.177089. Gut. 2010. PMID: 19671542 Clinical Trial.
-
Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.Gut. 2009 Feb;58(2):241-8. doi: 10.1136/gut.2008.156448. Epub 2008 Oct 13. Gut. 2009. PMID: 18852257
-
Options for screening for colorectal cancer.Scand J Gastroenterol Suppl. 2003;(237):13-6. doi: 10.1080/00855910310001421. Scand J Gastroenterol Suppl. 2003. PMID: 12797674 Review.
-
Clinical significance of small polyps found during screening with flexible sigmoidoscopy.Gastrointest Endosc Clin N Am. 2002 Jan;12(1):41-51. doi: 10.1016/s1052-5157(03)00056-4. Gastrointest Endosc Clin N Am. 2002. PMID: 11916160 Review.
Cited by
-
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.BMC Med. 2011 Dec 14;9:133. doi: 10.1186/1741-7015-9-133. BMC Med. 2011. PMID: 22168215 Free PMC article.
-
Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial.BMJ. 2009 May 29;338:b1846. doi: 10.1136/bmj.b1846. BMJ. 2009. PMID: 19483252 Free PMC article. Clinical Trial.
-
Primary and secondary prevention of colorectal cancer.Clin Med Insights Gastroenterol. 2014 Jul 14;7:33-46. doi: 10.4137/CGast.S14039. eCollection 2014. Clin Med Insights Gastroenterol. 2014. PMID: 25093007 Free PMC article. Review.
-
Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis.BMJ Open. 2019 Oct 2;9(10):e032773. doi: 10.1136/bmjopen-2019-032773. BMJ Open. 2019. PMID: 31578199 Free PMC article.
-
Disparities in endoscopy use for colorectal cancer screening in the United States.Dig Dis Sci. 2014 Mar;59(3):530-7. doi: 10.1007/s10620-013-2937-x. Epub 2013 Nov 19. Dig Dis Sci. 2014. PMID: 24248417 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical